title: Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life.
abstract: Humoral and cell-mediated immune responses (CMI) were evaluated in subjects 3 and 6 years after primary and booster vaccination with either three-component acellular (Pa) or whole-cell (Pw) vaccines. Low anti-pertussis toxin (PT) antibody levels confirmed the absence of pertussis disease, consistent with ongoing protection. Anti-pertactin (PRN) antibodies, remained at higher levels in Pa-vaccinated subjects. At year 6, CMI responses continued to be present and were higher in Pa-vaccinated than Pw-vaccinated subjects. Long-term protection with Pa vaccines can be expected to be at least as good as that provided by efficacious Pw vaccines.
authors.affiliation: Unité de Prévention et Thérapies Moléculaires des Maladies Humaines-FRE-CNRS 2849, Institut Pasteur, 25 rue du Dr. Roux, 75724 Paris Cedex 15, France. nguiso@pasteur.fr
authors.forename: N
authors.initials: N
authors.lastname: Guiso
authors.forename: E
authors.initials: E
authors.lastname: Njamkepo
authors.forename: F
authors.initials: F
authors.lastname: Vié le Sage
authors.forename: F
authors.initials: F
authors.lastname: Zepp
authors.forename: C U
authors.initials: CU
authors.lastname: Meyer
authors.forename: V
authors.initials: V
authors.lastname: Abitbol
authors.forename: N
authors.initials: N
authors.lastname: Clyti
authors.forename: S
authors.initials: S
authors.lastname: Chevallier
mesh_terms: D000917:Antibody Formation / Q000276:immunology; D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology; D001886:Bordetella pertussis / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage* / Q000276:immunology*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D018073:Haemophilus Vaccines / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007117:Immunization, Secondary / Q000379:methods*; D007223:Infant; D008213:Lymphocyte Activation / Q000276:immunology; D008222:Lymphokines / Q000276:immunology; D037342:Pertussis Toxin / Q000276:immunology; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000276:immunology; D010566:Virulence Factors, Bordetella / Q000276:immunology
chemical_list: D001425:Bacterial Outer Membrane Proteins; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D008222:Lymphokines; D011135:Polysaccharides, Bacterial; D010566:Virulence Factors, Bordetella; C068929:pertactin; D037342:Pertussis Toxin